Pdb60 - Cost-Consequence Analysis for Recombinant Human Growth Hormone Treatment Administered via Different Devices in Children With Growth Hormone Deficiency in Italy

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.765
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search